Follicles stop growing when one or more of the hormonal, metabolic, or structural signals they depend on goes wrong. In a typical menstrual cycle, a surge of follicle-stimulating hormone (FSH) recruits a batch of small follicles, and one of them outcompetes the rest to reach ovulation. When that process stalls, the cause usually traces back to disrupted hormone signaling, but the disruption itself can come from a surprisingly wide range of places, from your thyroid gland to your body fat to the physical stiffness of your ovarian tissue.
What Drives Normal Follicle Growth
Your ovaries contain thousands of tiny primordial follicles, each holding an immature egg. Early follicle development happens without any hormonal input from the brain. But once follicles reach a certain size, they become dependent on two hormones released by the pituitary gland: FSH and luteinizing hormone (LH).1PubMed Central. The role of LH in follicle development: from physiology to new clinical implications FSH acts on the granulosa cells surrounding the egg, making them multiply and start producing estrogen. The most responsive follicle becomes the “dominant” one, growing large enough to ovulate after LH triggers the final rupture.2PubMed. Gonadotropic control of ovarian follicular growth and development Anything that interferes with any link in that chain, from the brain’s hormone signals down to the granulosa cells themselves, can leave follicles stalled at a small size.
PCOS and the Crowded Ovary
Polycystic ovary syndrome is the single most common reason follicles fail to mature. In PCOS, the ovaries produce excess androgens (male-type hormones), and that excess actually speeds up the recruitment of early follicles, leaving the ovary packed with many small follicles in the 2 to 5 millimeter range. That sounds like it would be a good thing, but the crowd creates a problem: too many competing follicles interfere with each other’s ability to be selected for dominance. One of the key players in this interference is anti-Müllerian hormone (AMH), which the granulosa cells of those small follicles pump out in large quantities. The high AMH creates a kind of resistance to FSH, so no single follicle gets enough stimulation to pull ahead and mature.3Human Reproduction Update. The follicular excess in polycystic ovaries, due to intra‐ovarian hyperandrogenism, may be the main culprit for the follicular arrest
Insulin resistance acts as a second hit in many people with PCOS. When cells respond poorly to insulin, the body compensates by producing more of it, and that extra insulin amplifies the ovary’s androgen production, making the follicular arrest worse. This is why lifestyle changes and medications that improve insulin sensitivity, like metformin, sometimes help restore ovulation in PCOS even though they have nothing directly to do with FSH or LH.
When the Brain Stops Sending Signals
Your hypothalamus, a small region at the base of the brain, acts as the master switch for reproduction. It releases gonadotropin-releasing hormone (GnRH) in pulses, which tells the pituitary gland to secrete FSH and LH. In functional hypothalamic amenorrhea, that GnRH signal slows down or shuts off entirely, and without it, your pituitary never gets the instruction to produce the hormones your follicles need.4PubMed Central. Current understanding of hypothalamic amenorrhoea
The three main triggers are significant weight loss, intense exercise, and psychological stress. Your brain essentially decides that conditions aren’t favorable for pregnancy and conserves energy by shutting down the reproductive axis. This is not a permanent problem in most cases: restoring adequate calorie intake, reducing exercise intensity, or addressing chronic stress often allows the hypothalamus to resume its GnRH pulses. But while it’s happening, follicles sit dormant because they never receive the FSH signal they need to grow.
Running Low on Eggs
Premature ovarian insufficiency, sometimes called premature ovarian failure, is a different situation entirely. Here, the ovary’s pool of primordial follicles has been depleted or damaged far earlier than expected. In most cases, the mechanism behind this early depletion is unknown.5PubMed. Primary ovarian insufficiency But known causes include genetic conditions, chemotherapy, radiation therapy, and ovarian surgery.6The Lancet. Primary ovarian insufficiency When few primordial follicles remain, the pituitary pumps out more and more FSH in an attempt to recruit them, which is why blood tests in these cases often show abnormally high FSH levels. The hormonal signal is screaming, but there aren’t enough follicles left to respond.
Even without full premature ovarian insufficiency, age steadily reduces both the number and quality of follicles. As ovarian reserve shrinks, the remaining follicles tend to respond more poorly to stimulation, producing fewer mature eggs. This decline in follicle quality is thought to be driven more by changes in the eggs themselves than by problems with the uterine lining.7PubMed Central. ART outcome in young women with premature ovarian aging The practical upshot: if you’re being monitored during fertility treatment and your follicles aren’t growing well, age-related reserve decline is one of the first things your doctor will consider.
Thyroid and Prolactin Problems
Your thyroid gland might seem unrelated to your ovaries, but thyroid hormones regulate the metabolism and development of ovarian tissue. Both an underactive thyroid and an overactive one can disrupt follicle growth, leading to irregular cycles or complete anovulation.8Oxford Academic (Biology of Reproduction). Thyroid hormones and female reproduction Thyroid problems are relatively easy to screen for with a simple blood test, and treatment with thyroid medication often restores normal ovulation. This makes thyroid dysfunction one of the more fixable causes of poor follicle growth.
Prolactin, the hormone best known for triggering breast milk production, also regulates the reproductive axis. When prolactin levels are abnormally high, a condition called hyperprolactinemia, it suppresses GnRH release from the hypothalamus, which in turn starves follicles of the FSH and LH they need.9Oxford Academic (Reproduction). Reproductive role of prolactin Causes range from benign pituitary tumors to certain medications, particularly some psychiatric drugs. Like thyroid disorders, hyperprolactinemia is often treatable once identified.
Body Weight and Leptin Resistance
Body fat is an endocrine organ in its own right: it produces hormones and signaling molecules that influence the ovary directly. In obesity, fat tissue produces excess estrogen and large amounts of leptin, a hormone that normally helps regulate energy balance. When leptin levels stay chronically high, the ovaries can develop a form of leptin resistance, meaning they stop responding normally to leptin’s signals. This disrupts the internal environment of the follicle and impairs the egg’s ability to mature properly.10PubMed Central. Revisiting the Impact of Local Leptin Signaling in Folliculogenesis and Oocyte Maturation in Obese Mothers The disruption affects not only the growing egg but also the somatic cells surrounding it, compromising the follicle’s development at multiple levels.11PubMed Central. Maternal obesity and ovarian failure: is leptin the culprit?
Being significantly underweight causes problems from the opposite direction, as mentioned in the hypothalamic amenorrhea section. The brain interprets insufficient body fat as a sign that energy stores are too low to support a pregnancy. The result is the same: follicles don’t get the hormonal signals they need. The relationship between weight and follicle growth is genuinely U-shaped, with both extremes causing trouble.
Stress and Cortisol
Chronic psychological stress raises cortisol levels, and cortisol directly interferes with follicle function. Elevated cortisol reduces estradiol production by affecting the granulosa cells inside the follicle, which leads to poorer egg quality and slower growth.12PubMed Central. Impact of stress on oocyte quality and reproductive outcome Stress also suppresses GnRH at the brain level, compounding the problem. This is one reason fertility clinics often see improved responses to stimulation when patients address anxiety and chronic stress, though the relationship is hard to study rigorously because stress is difficult to measure and control for.
Oxidative Stress Inside the Follicle
Separate from the psychological kind, oxidative stress refers to an imbalance between damaging reactive oxygen species (ROS) and the antioxidant defenses that normally neutralize them. Inside the ovary, moderate levels of ROS are actually part of normal signaling, but when they accumulate, they trigger apoptosis, the programmed death of granulosa cells, and this pushes follicles toward atresia (a term for follicles that stop growing and degenerate).13PubMed Central. Roles of reactive oxygen species and antioxidants in ovarian toxicity Oxidative stress damages mitochondria in granulosa cells, reducing the metabolic support they provide to the developing egg.14PubMed Central. Oxidative Stress and SIRT1-Nrf2 Anti-Ferroptotic Pathways in Granulosa Cells: A Molecular Key to Follicular Atresia and Ovarian Aging
What drives oxidative stress in the ovary? Aging is a major one, since antioxidant defenses naturally weaken over time. Environmental toxins, smoking, and certain chemicals can also deplete protective antioxidants like glutathione. When glutathione is depleted, antral follicles are especially vulnerable to atresia.13PubMed Central. Roles of reactive oxygen species and antioxidants in ovarian toxicity
Environmental Chemicals That Disrupt Follicle Growth
Endocrine-disrupting chemicals, substances that mimic or interfere with hormones, are an underappreciated threat to follicle development. Compounds like bisphenol A (BPA), phthalates, dioxins, and certain pesticides can all affect the ovary’s ability to grow follicles and produce steroid hormones.15PubMed Central. Effects of Endocrine-Disrupting Chemicals on the Ovary BPA, which is found in some plastics and food-container linings, has been shown in lab studies to inhibit follicle growth and induce atresia through a pathway that doesn’t even require the classical estrogen receptor. It disrupts cell-cycle regulators and tips the balance toward apoptosis in antral follicles.16PubMed Central. Bisphenol A inhibits follicle growth and induces atresia in cultured mouse antral follicles independently of the genomic estrogenic pathway
These findings come largely from animal and cell-culture studies, so the exact dose at which everyday exposure becomes a problem for human follicle growth is still debated. But the consistency of the evidence across multiple chemicals and multiple research groups has made endocrine disruptors a serious concern in reproductive medicine. Reducing exposure where practical, such as avoiding BPA-lined containers and choosing phthalate-free products, is a reasonable precaution even if we can’t yet quantify how much benefit it provides for follicle growth specifically.
Blood Supply and Ovarian Stiffness
Growing follicles need a blood supply. Angiogenesis, the process of building new blood vessels, is tightly linked to follicle maturation. Vascular endothelial growth factor (VEGF) is the key molecule driving this process, and healthy follicles express more of it than atretic ones.17PubMed. Vascular endothelial growth factor and angiopoietins during hen ovarian follicle development When VEGF signaling is blocked experimentally, follicles can progress partway through development but cannot reach the preovulatory stage. They stall because without new blood vessel growth, the follicle can’t form a proper fluid-filled cavity (antrum) and can’t receive the oxygen and nutrients it needs to keep expanding.18JCI Insight. Vascular endothelial growth factor receptor 2–mediated angiogenesis is essential for gonadotropin-dependent follicle development Conditions that impair blood flow to the ovaries, whether from surgery, endometriosis, or other causes, may contribute to poor follicle growth through this mechanism.
Physical stiffness of the ovarian tissue itself is an emerging area of research. As ovaries age, their surrounding matrix becomes stiffer. Lab experiments using alginate gels of different densities have shown that follicles grown in stiffer environments simply stop expanding, reaching much smaller final sizes than those in softer environments.19PubMed Central. Age-associated increased stiffness of the ovarian microenvironment impairs follicle development and oocyte quality and rapidly alters follicle gene expression This suggests that age-related follicle growth problems aren’t only about egg quality or hormonal changes. The physical scaffolding around the follicle may literally be too rigid for it to expand.
Genetic Variations in How Your Body Responds to FSH
Not everyone’s FSH receptors work the same way. Certain genetic variants in the FSH receptor gene can change how sensitive follicles are to FSH stimulation. One well-studied variant, a swap of one amino acid at position 680 of the receptor (asparagine to serine), has been linked to a poorer ovarian response during fertility treatment. Studies have found that women carrying the serine variant at this position are overrepresented among those who respond abnormally to stimulation.20PubMed Central. The Polymorphism Asn680Ser on the FSH Receptor and Abnormal Ovarian Response in Patients with Normal Values of AMH and AFC Another variant at position 160 has also been found more frequently in women undergoing fertility treatment compared to women with normal fertility.21PubMed. Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation
The picture is far from clear-cut, though. At least one study found that common FSH receptor variants don’t significantly influence how well antral follicles respond to FSH in terms of measurable output.22PubMed Central. Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT) The practical takeaway: genetic differences in FSH receptor sensitivity may explain why some people with apparently normal hormone levels and normal egg counts still respond poorly to stimulation, but this isn’t yet something routinely tested for or used to guide treatment decisions.
AMH as an Internal Brake
AMH comes up frequently in fertility testing as a marker of ovarian reserve, but it also plays an active role in controlling follicle growth. AMH produced by small growing follicles inhibits the recruitment of new primordial follicles, acting as a brake that prevents too many follicles from entering the growth pipeline at once. In lab models, AMH was shown to inhibit the initial assembly of primordial follicles, shrinking the starting pool, and to alter the expression of over 200 genes during that process.23PubMed Central. Inhibitory actions of Anti-Müllerian Hormone (AMH) on ovarian primordial follicle assembly
In PCOS, AMH levels are often two to three times higher than normal, which is part of why the selection of a dominant follicle fails. The excess AMH makes the growing follicles resistant to FSH, keeping many of them at a small size rather than allowing one to mature. Conversely, very low AMH indicates that few follicles remain and the braking system has weakened, which is part of the picture in premature ovarian insufficiency and age-related decline.
What Treatment Options Exist
The treatment depends entirely on the underlying cause. For PCOS, the most common medical approach involves ovulation-induction medications. Clomiphene citrate and letrozole are the first-line options. In one study of PCOS patients using a combination of letrozole and clomiphene, about 83% of treatment cycles produced at least one dominant follicle, and the pregnancy rate was 42%.24PubMed Central. Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome When oral medications alone aren’t enough, injectable gonadotropins (FSH and sometimes LH) provide a stronger push, though they require careful monitoring to avoid overstimulating the ovaries.
For hypothalamic amenorrhea, addressing the root cause is the first step: gaining weight if underweight, reducing exercise volume, or managing chronic stress. If natural cycles don’t return, pulsatile GnRH therapy or gonadotropin injections can restore follicle growth. For thyroid and prolactin issues, the fix is straightforward: correct the hormone imbalance with medication, and follicle development often resumes on its own.
When diminished ovarian reserve is the problem, treatment options become more limited. Higher doses of gonadotropins may coax a few more follicles to grow, but there’s a ceiling dictated by how many follicles remain. In vitro fertilization is often recommended because it maximizes the chances of capturing whatever follicles do respond.
Supplements and the CoQ10 Question
Coenzyme Q10 (CoQ10) has gained attention as a supplement that may support follicle growth, particularly in women with diminished ovarian reserve or those who are older. CoQ10 is a naturally occurring molecule involved in mitochondrial energy production, and since granulosa cells and eggs are both energy-intensive, the logic is reasonable. Clinical studies have found that CoQ10 supplementation can improve ovarian function, increase the number of eggs retrieved during IVF, and improve embryo quality.25PubMed Central. Exploring the protective effects of coenzyme Q10 on female fertility The proposed mechanism involves reducing oxidative stress and supporting mitochondrial efficiency in the follicle.
Vitamin D has also been studied for its role in follicle development and oocyte maturation, with receptors for vitamin D found in ovarian tissue. However, the evidence for a direct effect on follicle growth is less robust than for CoQ10. Most fertility specialists consider vitamin D worth checking and supplementing if deficient, but it’s unlikely to be the sole explanation for poorly growing follicles unless levels are extremely low. Neither supplement replaces medical evaluation and treatment for the underlying causes described above, but they may provide incremental benefit as part of a broader approach.